SCHEMBL3343357

SCHEMBL3343357

COc1cc(N)c(Br)cc1C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.53
CYP1A2 P05177 1/20 0.53
HTR1A P08908 1/20 0.53
ADRA2A P08913 1/20 0.53
CYP2D6 P10635 1/20 0.53
DRD1 P21728 1/20 0.53
PTGS1 P23219 1/20 0.53
DRD3 P35462 1/20 0.53
HTT P42858 2/20 0.47
TSHR P16473 1/20 0.47
APOBEC3A P31941 1/20 0.47
APOBEC3G Q9HC16 1/20 0.47
KDM4E B2RXH2 2/20 0.47
GAA P10253 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
POLB P06746 1/20 0.46
HTR4 Q13639 2/20 0.44
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
ALDH1A1 P00352 5/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL866041 0.87 LCK (0.59) ACHECYP1A2HTR1AADRA2ACYP2D6
SCHEMBL17653164 0.86 KDM4E (0.51) ACHECYP1A2HTR1AADRA2ACYP2D6
SCHEMBL3343354 0.85 LCK (0.56) HTTTSHRAPOBEC3AAPOBEC3GKDM4E
SCHEMBL9793655 0.85 KDM4E (0.53) CYP1A2CYP2D6HTTTSHRAPOBEC3A
SCHEMBL169553 0.84 GAA (0.66) ACHECYP1A2HTR1AADRA2ACYP2D6
SCHEMBL6811690 0.84 KDM4E (0.49) ACHECYP1A2HTR1AADRA2ACYP2D6
SCHEMBL6814511 0.83 KDM4E (0.56) HTTTSHRKDM4EGAAL3MBTL1
Hydrochloric Acid SCHEMBL7410965 0.83 GAA (0.64) ACHECYP1A2HTR1AADRA2ACYP2D6
SCHEMBL3853270 0.82 TSHR (0.47) HTTTSHRAPOBEC3AAPOBEC3GKDM4E
SCHEMBL27433126 0.81 HTT (0.46) HTTTSHRAPOBEC3AAPOBEC3GKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393781-B1 DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
US-20100160388-A1 DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160388-A1 DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS P2RY1, P2RX1, P2RX3 ACHE 2602/4885CYP1A2 2344/4885HTR1A 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.